1Wilson TA,Ros SR,Cohen P,et al.Update of guidelines for the use of growth hormone in children:the Lowson Wilkins pediatric endocrinology society drug and therapeutics committee.J Pediatr,2003,143:415-421.
2Cohen P,Brght GM,Rozol AD,et al.Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children:implications for efficacy and safety.J Clin Endocrinol Metab,2002,87(1):90-98.
3A report by drug and therapeutic committee of the Lowson Wilkins pediatric endocrine society:guidelines for the use of growth hormone in children with short stature.J Pediatr,1995,127:857-867.
4Cassorla F,Mericq V,Eqqers M,et al.Effects of luteinizing hormone-releasing hormone analogue-induced pubertal delay in growth hormone (GH)deficient children treated with GH:preliminary results.J Clin Endocrinol Metab,1997,82:2987-2992.
5Marrin G,Domene HM,Barnes KM,et al.The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys.J Clin Endocrinol Metab,1994,79:537-541.
7De Boer H,vander Veen EA.Why retest young adults with childhood-onset growth hormone deficiency.J Clin Endocrinol Metab,1997,82:2032-2036.
8Celniker AC,Chen AB,Went RM,et al.Variability in the quatitation of circulating growth hormone using commercial immunoassays.J Clin Endocrinol Metab,1989,68:469-476.
9Swerdlow AJ,Higgins CD,Adlard P,et al.Risk of cancer in patients with human pituitary growth hormone in UK,1959-1985,a cohort study.Lancet,2002,360:273-277.
10Fradk IJE,Mills JL,Schonherger LB,et al.Risk of leukemia after treatment with pituitary growth hormone.JAMA,1993,270:2829-2832.
2Rosenfeld NG, Albertsson-Wikland K, Cassorla F, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab, 1995,80:1532-1540.
3Tanner JM, Davies PSW. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr, 1985,107:317-329.
4Ghigo E, Bellone J, Aimaretti G, et al. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab, 1996,81:3323-3327.
5Friend K, Iranmanesh A, Login IS, et al. Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release. Eur Endocrinol J, 1997,137:377-3
6Shah A, Stanhope R, Matthews D. Harzards of pharmacological tests of growth hormone secretion in childhood. Br Med J, 1992,304:173-174.
7Carel CJ, Tresca JP, Letrait M, et al. Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. J Clin Endocrinol Metab, 1997,82:2117-2121.
8Tillmann V, Buckler JMH, Kibirige MS, et al. Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab, 1997,82:531-535.
